“Immunotherapy is a game-changer” – Glenys’ story 04 Sep 2023 Glenys Gregory recently became a grandmother, but at one point, she’d wondered if she would live to see him born. In January 2020, Glenys was diagnosed with advanced lung cancer after nursing her mother through the same disease. Due to the coronavirus pandemic, she went straight onto immunotherapy and a scan in summer 2023 revealed that she had no evidence of disease. Here she tells her story. Find out more Show/Hide
ASCO 2022: ICR researchers hit the headlines with innovative approaches to cancer treatment and care 08 Jun 2022 The first in-person ASCO conference since the start of the Covid-19 pandemic took place in Chicago over the weekend. Many researchers from the ICR and The Royal Marsden presented their work in the form of talks or posters. Here we look back over some of our highlights of this year’s meeting. Find out more Show/Hide
Five steps to improve access to cancer immunotherapies 23 Nov 2020 Immunotherapies are some of the most innovative new cancer treatments available to patients, but more needs to be done to get them to as many patients as possible. Policy Officer Aislinn Santoni looks at the barriers to wider access and what we can do to overcome them. Find out more Show/Hide
Prostate Cancer Awareness Month 2019: Six of the latest advances in prostate cancer research 13 Mar 2019
Reducing inequalities, immunotherapy and quality of life: three key themes from NCRI 2018 08 Nov 2018
Nobel Prize for Medicine 2018: the early research that led to ‘revolutionary’ cancer immunotherapy 01 Oct 2018
ASCO 2018: World’s largest cancer conference seeks to expand the reach of precision medicine 01 Jun 2018